Renal kinin and kallikrein excretion in cirrhotic patients. 1991

N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
Dept. of Internal Medicine, Osaka Police Hospital, Japan.

Urinary kinin and urinary kallikrein activity were measured in 33 liver cirrhotics, and the values were correlated with the severity of the liver disease. A significant relationship was observed between urinary kinin excretion and urinary kallikrein excretion (r = 0.53; p less than 0.01). Both urinary kinin and kallikrein excretion were significantly lower in Child's group C than in Child's groups A and B (p less than 0.05) and showed positive correlations with serum albumin (r = 0.47, p less than 0.01 and r = 0.46, p less than 0.01, respectively). Increases in urinary kinin and kallikrein excretion after endoscopic variceal sclerotherapy were observed in 18 patients (p less than 0.01 and p less than 0.05, respectively). These results suggest that the renal kallikrein-kinin system in suppressed in severe liver disease in proportion to the severity of the underlying liver disease. In this study possible activation of this system after sclerotherapy was also demonstrated.

UI MeSH Term Description Entries
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004932 Esophageal and Gastric Varices Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL). Esophageal Varices,Gastric Varices,Esophageal Varix,Gastric Varix,Varices, Esophageal,Varices, Gastric,Varix, Esophageal,Varix, Gastric
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum
D015911 Sclerotherapy Treatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage by injection or infusion of chemical agents which cause localized thrombosis and eventual fibrosis and obliteration of the vessels. Sclerotherapies

Related Publications

N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
July 1982, Quarterly journal of experimental physiology (Cambridge, England),
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
January 1986, Kidney international,
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
December 1992, Nihon rinsho. Japanese journal of clinical medicine,
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
September 1984, Scandinavian journal of gastroenterology,
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
February 1976, Federation proceedings,
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
April 1980, The American journal of physiology,
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
April 1979, Circulation research,
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
May 1982, Clinical nephrology,
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
January 1981, Giornale italiano di cardiologia,
N Yuki, and M Kubo, and Y Noro, and N Hayashi, and H Fusamoto, and A Ito, and M Masuzawa, and T Kamada
May 2005, Experimental physiology,
Copied contents to your clipboard!